跳至主要内容
临床试验/NCT00794196
NCT00794196已完成不适用

Impact of the Pharmaceutical Care Program for Pharmacological Treatment of Depression in Primary Care on the Compliance to Antidepressants and Patient Wellbeing

Fundació Sant Joan de Déu2 个研究点 分布在 1 个国家目标入组 179 人开始时间: 2008年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
179
试验地点
2
主要终点
Adherence to Antidepressant Medication

研究概览

简要总结

The purpose of this study is to evaluate the impact of pharmaceutical services among patients starting a treatment with antidepressants for a diagnosis of depression. The hypothesis of the study is that pharmacist intervention can improve compliance to antidepressants and patient wellbeing.

详细描述

The aim of this study is to evaluate the efficacy of a support program in community pharmacy on the improvement of the compliance to antidepressants and the clinic of typical primary care patients under normal practice circumstances. That implies that the intervention is made by pharmacists without any specific requirement that work in the community pharmacies set up in the area of study and on patients following the usual medical circuit. As well, the cost of the support program is calculated in order to set the effectiveness of the program.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis for depression from a general practitioner
  • Beginning a pharmacological antidepressant treatment
  • Going to one of the participant community pharmacies

排除标准

  • Used antidepressant medication in the past 2 months
  • Had an appointment with an specialist in mental disorders in the past 2 months
  • History of psychotic or bipolar episodes
  • History of drug abuse or dependency
  • Cognitive impairment that not allows assessment

研究组 & 干预措施

Usual Care

No Intervention

The control group will be receiving usual medical and pharmaceutical care.

Intervention Group

Experimental

Intervention group will be receiving usual medical and pharmaceutical care plus a pharmaceutical support program.

干预措施: Pharmaceutical care program for antidepressant treatment (Behavioral)

结局指标

主要结局

Adherence to Antidepressant Medication

时间窗: At 3 and 6 months

Adherence to antidepressant medication was measured through Pharmacy records

次要结局

  • Patient Wellbeing(0, 3 and 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Antoni Serrano Blanco

Antoni Serrano Blanco

Fundació Sant Joan de Déu

研究点 (2)

Loading locations...

相似试验

Pharmaceutical Care Program for Pharmacological... | 临床试验